NYSE:MED - Medifast Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$119.07 +3.37 (+2.91 %)
(As of 01/17/2019 05:33 AM ET)
Previous Close$115.70
Today's Range$114.96 - $119.59
52-Week Range$61.96 - $260.98
Volume351,300 shs
Average Volume386,927 shs
Market Capitalization$1.30 billion
P/E Ratio52.00
Dividend Yield2.75%
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples


Current Ratio2.42
Quick Ratio1.72


Sales & Book Value

Annual Sales$301.56 million
Price / Sales4.73
Cash Flow$2.9925 per share
Price / Cash Flow39.79
Book Value$9.10 per share
Price / Book13.08


Net Income$27.72 million
Net Margins10.95%
Return on Assets30.19%


Market Cap$1.30 billion

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Wednesday, December 12th. Investors of record on Friday, December 21st will be given a dividend of $0.75 per share on Thursday, February 7th. This represents a $3.00 annualized dividend and a yield of 2.52%. The ex-dividend date is Thursday, December 20th. This is an increase from Medifast's previous quarterly dividend of $0.48. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) issued its quarterly earnings data on Tuesday, November, 6th. The specialty retailer reported $1.14 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $1.14. The specialty retailer earned $139.20 million during the quarter, compared to analysts' expectations of $125.20 million. Medifast had a net margin of 10.95% and a return on equity of 43.45%. The company's revenue was up 80.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.55 earnings per share. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, March 5th 2019. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY18 earnings guidance on Monday, January, 14th. The company provided earnings per share (EPS) guidance of $4.45-4.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.50. The company issued revenue guidance of $492.5-497.5 million, compared to the consensus revenue estimate of $497.04 million.

What price target have analysts set for MED?

2 brokerages have issued twelve-month price objectives for Medifast's shares. Their predictions range from $249.00 to $249.00. On average, they anticipate Medifast's share price to reach $249.00 in the next twelve months. This suggests a possible upside of 109.1% from the stock's current price. View Analyst Price Targets for Medifast.

What is the consensus analysts' recommendation for Medifast?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast.

Has Medifast been receiving favorable news coverage?

News headlines about MED stock have been trending somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medifast earned a news impact score of 1.8 on InfoTrie's scale. They also gave press coverage about the specialty retailer a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:
  • Mr. Daniel R. Chard, CEO & Director (Age 53)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)
  • Mr. Bill Baker, Exec. VP of Information Technology (Age 46)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Tony Tyree, Chief Marketing Officer

Who are Medifast's major shareholders?

Medifast's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Chickasaw Capital Management LLC (0.28%), Navellier & Associates Inc (0.22%), Virtu Financial LLC (0.05%), Louisiana State Employees Retirement System (0.04%), State of Alaska Department of Revenue (0.03%) and First Citizens Bank & Trust Co. (0.02%). Company insiders that own Medifast stock include Charles P Connolly, Constance J Hallquist, Daniel R Chard, Glenn W Welling, Jeremy John Martin, Michael A Hoer, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

Which institutional investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including Chickasaw Capital Management LLC, Louisiana State Employees Retirement System and First Citizens Bank & Trust Co.. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Constance J Hallquist and Michael C Macdonald. View Insider Buying and Selling for Medifast.

Which institutional investors are buying Medifast stock?

MED stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Navellier & Associates Inc and State of Alaska Department of Revenue. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Glenn W Welling, Michael A Hoer and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $119.07.

How big of a company is Medifast?

Medifast has a market capitalization of $1.30 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

What is Medifast's official website?

The official website for Medifast is http://www.medifast1.com.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]

MarketBeat Community Rating for Medifast (NYSE MED)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  252 (Vote Outperform)
Underperform Votes:  272 (Vote Underperform)
Total Votes:  524
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Featured Article: What is Depreciation?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel